Amundi has sold 148,140 shares of
Celanese Corporation (CE), contributing to a 13% drop in the stock following a disclosure of another inventory destocking. Despite these challenges,
Celanese's cost discipline may counteract softer demand in an unpredictable market. Meanwhile, MetLife Investment Management LLC and Corebridge Financial Inc. have also reduced their positions in CE, leading to further devaluation of the stock. Despite near-term uncertainty,
shareholders could still see significant returns once times of uncertainty abate. RBC Capital reduced the price target for CE due to
inventory pressures. Meanwhile, the company has seen significant investments from various entities such as Sciencast Management LP and Kayne Anderson Rudnick Investment Management LLC, acquiring thousands of shares. The forecast for CE's stock price remains
pessimistic due to declining earnings reports and increased analyst downgrades. Among numerous investors' reports, Celanese's financial position has seen both decreases and increases in stake holdings, with potential concerns about the recent drop in metrics and its implications on Celanese's Q2 2025 earnings. Despite stagnation, Celanese strengthened its financial position with a new $1.75B credit facility addition to its $1.2B cash reserve. Amid falling stock value and weak demand, stock insiders continue to acquire shares, suggesting a possible future turnaround.
Celanese Corporation CE News Analytics from Wed, 06 Nov 2024 08:00:00 GMT to Sat, 13 Sep 2025 23:24:16 GMT -
Rating -4
- Innovation 0
- Information 6
- Rumor -3
